NBDC Research ID: hum0270.v1

 

SUMMARY

Aims: To identify prognosis-related genomic alterations in pediatric Osteosarcoma patients using NGS technique.

Methods: By using a comprehensive cancer panel which amplifies coding exons of cancer-related 409 genes, candidate mutations occurred in OS were surveyed.

Participants/Materials: Pediatric Osteosarcoma: 16 patients

 

Dataset IDType of DataCriteriaRelease Date
JGAS000282 NGS (Target Capture) Controlled-access (Type I) 2022/05/19

*Release Note 

*Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more

 

MOLECULAR DATA

JGAS000282

Participants/Materials Pediatric Osteosarcoma (ICD10: C41.9): 16 cases
Targets Target Capture
Target Loci for Capture Methods 409 genes (Ion Ampliseq Comprehensive Cancer Panel)
Platform Thermo Fisher Scientific [Ion Torrent Proton]
Library Source DNAs extracted from tumor tissues and non-tumor tissues (or peripheral blood cells)
Cell Lines -
Library Construction (kit name) Ion AmpliSeq™ Library Kit 2.0
Fragmentation Methods -
Spot Type Single-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 155 bp on average
Japanese Genotype-phenotype Archive Dataset ID JGAD000388
Total Data Volume 131.3 GB(fastq)
Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Tsukasa Yonemoto

Affiliation: Division of Orthopedic Surgery, Chiba Cancer Center

Project / Group Name: -

Funds / Grants (Research Project Number):

NameTitleProject Number
KAKENHI Grant-in-Aid for Young Scientists (B) Molecular profiling to predict chemosensitivity for osteosarcoma 23791673
KAKENHI Grant-in-Aid for Scientific Research (C) Analysis of factors determining chemosensitivity and pulmonary metastasis in patients with osteosarcoma by genomic expression analysis 19591742
Grants-in-Aid by the Ministry of Health, Labor and Welfare of Japan for the Third Term Comprehensive 10-year Strategy for Cancer Control Genomic and gene expression profiling of pediatric solid tumors

 

PUBLICATIONS

TitleDOIDataset ID
1 CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma doi: 10.3892/or.2021.8086 JGAD000388
2

 

USRES (Controlled-access Data)

Principal InvestigatorAffiliationCountry/RegionResearch TitleData in Use (Dataset ID)Period of Data Use